AUSTIN, United States, Feb. 25, 2026 (GLOBE NEWSWIRE) — The global healthcare business intelligence market is poised for significant expansion, driven by rising demand for predictive analytics, cloud-based business intelligence (BI) platforms, and regulatory quality reporting requirements. According to a new report by SNS Insider, the market size is projected to grow from an estimated USD 8.32 billion in 2025 to USD 20.04 billion by 2035, registering a compound annual growth rate (CAGR) of 9.19% from 2026 to 2035. This growth is attributed to the increasing volume of healthcare data, regulatory demands for quality reporting, and an organizational focus on operational efficiency improvements.
The U.S. healthcare business intelligence market alone is expected to achieve a CAGR of 9.21% over the same period, expanding from USD 3.28 billion in 2025 to USD 7.90 billion by 2035. Key factors propelling this growth include federal regulations promoting healthcare analytics, a well-established IT infrastructure, and the necessity for compliance with quality reporting requirements.
The adoption of value-based care and regulatory quality reporting standards are pivotal to the market’s expansion. These elements are bolstered by the implementation of the CMS quality payment programs aimed at enhancing performance measurement and outcome-based reimbursement. Such frameworks, including MIPS reporting standards and MACRA guidelines, are foundational to the increased market penetration of both on-premises and cloud-based solutions, which are crucial for healthcare quality improvement and cost optimization.
However, the market may face challenges due to the complex nature of data integration and interoperability. Many healthcare organizations encounter difficulties in linking disparate data sources, dealing with outdated systems, and managing incompatible data formats. These challenges can lead to inaccurate data, insufficient analytics capabilities, and a diminished return on investment for healthcare technologies. In regions where healthcare IT infrastructure is less developed, the lack of data standardization can further degrade decision-making quality, thus impeding overall market growth.
The report also highlights major players in the healthcare business intelligence sector. Notable companies include IBM Corporation, Oracle Corporation, Microsoft Corporation, SAP SE, and SAS Institute Inc., among others. These companies are positioned to leverage their technological capabilities to cater to the growing demand for healthcare analytics and BI solutions.
By component, the software segment accounted for approximately 59.47% of the market revenue in 2025, attributed to its comprehensive analytics capabilities and customizable dashboard features. Conversely, the services segment is anticipated to achieve the highest CAGR of nearly 9.68% from 2026 to 2035, driven by increasing demands for implementation support.
Geographically, the Asia Pacific region is expected to witness the fastest growth, boasting a CAGR of 10.87%. This growth is fueled by heightened awareness of data-driven healthcare management and government initiatives aimed at enhancing digital health capabilities. In contrast, North America represented over 39.42% of the market share in 2025, primarily due to its established healthcare analytics ecosystem and strict quality reporting requirements.
Recent developments in the industry underscore the ongoing shift towards advanced analytics. In February 2025, IBM expanded its healthcare BI platform capabilities through the integration of AI-driven predictive analytics and population health management tools aimed at improving clinical decision support. Meanwhile, in May 2024, Oracle unveiled an enhanced cloud-based healthcare BI solution that features real-time clinical analytics and integrated financial performance dashboards, improving data accessibility and quality measurement capabilities across global markets.
As the healthcare business intelligence market continues to evolve, organizations are increasingly focused on leveraging technology to make data-driven decisions that enhance clinical outcomes and operational efficiency. The ongoing challenges related to data integration and interoperability will need to be addressed for the market to realize its full potential. Nevertheless, the increasing trend towards value-based care and quality reporting is expected to fuel further expansion in this vital sector of healthcare.
See also
Nvidia Invests $30B in OpenAI, Backs 10 AI Startups Amid $4.5T GPU Boom
Block Cuts 40% of Workforce Amid AI Integration, Shares Surge 16%
OpenAI Secures Pentagon Deal for AI Deployment, Phasing Out Anthropic Technology
Nu Holdings Achieves Conditional US Bank Charter, Launches AI-Powered Credit Underwriting
SaaS Market Resilient Amid AI Rumors; Analysts Predict No Imminent Collapse
